Upravit stránku

Dr. Roman Košek

Internal medicine

Dr. Roman Košek

Internal medicine

Education

2009specialised qualification in the field of internal medicine
2009functional licence F016 – Artificial nutrition and metabolic care
19972nd attestation in internal medicine – Institute of Postgraduate Medical Education, Prague
19921st attestation in internal medicine – Institute of Postgraduate Medical Education, Prague
1983 – 1989Faculty of Medicine, Charles University Prague

 

Work experience

Od 1.3.2019Program Health Plus
2008 – 2019Head Physician, Department of Internal Medicine, Mladá Boleslav Regional Hospital
2010 – 2011External teacher, 3rd Faculty of Medicine, Charles University Prague
1997 – 2007Assistant head physician, Department of Internal Medicine, Mladá Boleslav Hospital
1989 – 1996Department of Internal Medicine, Mladá Boleslav Hospital - secondary doctor and work at inpatient department of internal medicine and gastroenterology endoscopy department

 

Membership of professional associations

  • Czech Society of Gastroenterology of the Czech Medical Association J.E.Purkyne - member
  • Czech Society of Internal Medicine of the Czech Medical Association J.E.Purkyne - member

Participation in research projects

  • 2013 - Study NN2211-3867. Clinical phase 4, comparing the efficacy of liraglutide versus lixisenatide as adjuvant therapy for patients treated with metformin.
  • 2010 – Study BI 1245.28, Clinical phase 3, comparing the efficacy and safety of administering product BI 10773 in comparison with glimepiride. Tested substance: BI 10773, selective inhibitor Na-glucose co-transporter 2 (SGLT-2).
  • 2010 - Study NN1250-3724 insulin SIBA (soluble insulin basal analogue) in comparison with insulin glargine in patients with type 2 DM, clinical phase 3
  • 2009 – Study no. 1218.36, clinical phase 3 linagliptin in combination with basal insulin for type 2 DM
  • 2005-2006 Study GWCL 0305, GWCL 0404 (efficacy of sativex in treatment of neuropathic pain in diabetics). Clinical phase 3
  • 2003-2005 Study EC 410, EC 404 (pioglitazone plus metformin versus gliclazide plus metformin in the therapy of type 2 diabetes mellitus). Clinical phase 3

Languages and other skills

  • German
  • passive English

Hobbies

  • Travelling
  • Cycling
  • Reading

This website uses cookies

For the proper operation of the website only necessary essential cookie files are activated. However, optional cookies must be enabled for full service delivery, ad personalization and traffic analysis. Use the following button to turn them on. More information.

Settings

Your privacy is important. You can choose from the cookie settings below. More information.